EIF2AK3 and RASopathy: Taken together, these data suggest that treatment with lovastatin using the same dosing regimen that was sufficient to rescue special learning and pERK hyper-activation in the Nf131 and Ptpn1110 RASopathy models, is not effective in rescuing the spatial learning deficit of HRasG12V/G12V mice.